1
|
Imamura S, Oda Y, Fukumoto T, Mizuno M, Suzuki M, Washio K, Nishigori C, Fukunaga A. Solar urticaria: clinical characteristics, treatment effectiveness, long-term prognosis, and QOL status in 29 patients. Front Med (Lausanne) 2024; 11:1328765. [PMID: 38435390 PMCID: PMC10904580 DOI: 10.3389/fmed.2024.1328765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Accepted: 01/29/2024] [Indexed: 03/05/2024] Open
Abstract
Introduction Solar urticaria (SU), a relatively rare skin inflammatory and photosensitivity disease, is often resistant to standard urticaria treatment. Quality of life (QOL) among SU patients has not been extensively explored. This study was performed to clarify the clinical features and effectiveness of therapies (e.g., hardening therapy) for SU and to determine QOL among SU patients. Methods The authors examined the characteristics, treatments, and QOL statuses of 29 Japanese SU patients using medical records and a questionnaire approach. Results Among 29 patients, H1 antihistamine therapy (H1) was effective in 22 (75.8%) patients. H2 antihistamine therapy (H2) was effective in three of seven (42.9%) patients. Ultraviolet radiation A (UVA) hardening therapy was effective in eight of nine (88.9%) patients. Visible light (VL) hardening therapy was ineffective in three of three patients. In one patient who underwent both UVA and VL hardening therapy, only UVA hardening therapy was effective. In the questionnaire, 18 patients (90%) reported some improvement compared with disease onset (four had complete remission, six had completed treatment although mild symptoms persisted, and eight were receiving treatment with moderate symptoms), whereas two patients reported exacerbation. Patients in complete remission had a mean disease duration of 4 years, whereas patients not in remission had a mean disease duration of 8.8 years. The mean Dermatology Life Quality Index (DLQI) score for the current status was 7.4. There was a correlation between DLQI and symptom/treatment status. However, neither DLQI and action spectra nor DLQI and treatments exhibited significant differences. Discussion The questionnaire revealed current QOL status and long-term prognosis in SU patients. Compared with disease onset, most patients showed improvement when assessed for this study. Both H1 and H2 should be attempted for all SU patients. UVA hardening therapy may be an option for SU patients with an action spectrum that includes UVA.
Collapse
Affiliation(s)
- Shinya Imamura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
- Department of Dermatology, Kobe City Hospital Organization, Kobe City Medical Center West Hospital, Kobe, Japan
| | - Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Takeshi Fukumoto
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Mayuko Mizuno
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Mariko Suzuki
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
- Department of Dermatology, Osaka Medical and Pharmaceutical University, Osaka, Japan
| |
Collapse
|
2
|
Sasaki N, Saito-Sasaki N, Washio K, Takayama K, Sawada Y. Three Cases of Occupational Allergic Contact Dermatitis Where Causative Agents Were Identified Using Patch Test Panel S. Cureus 2023; 15:e45891. [PMID: 37885544 PMCID: PMC10599210 DOI: 10.7759/cureus.45891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/22/2023] [Indexed: 10/28/2023] Open
Abstract
Identifying the causative substances of occupational contact dermatitis is challenging because of several chemicals and materials in the workplace that can cause contact dermatitis. We experienced three cases of intractable eczema identified as work-related contact dermatitis by Patch Test Panel S, which helped identify the possible substances. We experienced three cases of occupational allergic contact dermatitis, and their causative agents were identified by Patch Test Panel S. Although there are some limitations, Patch Test Panel S might be useful to determine the substrates to cause allergic contact dermatitis in occupational scenarios.
Collapse
Affiliation(s)
- Naoki Sasaki
- Dermatology, University of Occupational and Environmental Health, Kitakyushu, JPN
| | - Natsuko Saito-Sasaki
- Dermatology, University of Occupational and Environmental Health, Kitakyushu, JPN
| | - Ken Washio
- Dermatology, Kobe City Nishi-Kobe Medical Center, Kobe, JPN
| | - Kaoru Takayama
- Dermatology, Saiseikai Kawaguchi General Hospital, Kawaguchi, JPN
| | - Yu Sawada
- Dermatology, University of Occupational and Environmental Health, Kitakyushu, JPN
| |
Collapse
|
3
|
Fukunaga A, Oda Y, Imamura S, Mizuno M, Fukumoto T, Washio K. Cholinergic Urticaria: Subtype Classification and Clinical Approach. Am J Clin Dermatol 2023; 24:41-54. [PMID: 36107396 PMCID: PMC9476404 DOI: 10.1007/s40257-022-00728-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/26/2022] [Indexed: 01/26/2023]
Abstract
Cholinergic urticaria (CholU) is a subtype of chronic inducible urticaria with a chief complaint of itching and/or stinging, painful papular wheals that develop simultaneously with sweating. This review specifically focuses on several subtypes of CholU and specifically investigates the relationship between CholU and anhidrosis. We review recent publications and update the evidence around CholU, including the epidemiology, clinical features, diagnostic approaches, physiopathology, subtype classification, and therapeutic approaches. Multiple mechanisms contribute in a complex manner to the development of CholU, including histamine, sweat allergy, cholinergic-related substances, poral occlusion, and hypohidrosis/anhidrosis. A new schematic of the currently known pathological conditions has been created. Specific methods for diagnosing CholU, a provocation test, and evaluation methods for disease severity/activity and disease burden of CholU are summarized. The characteristics of the diseases that should be differentiated from CholU and examination methods are also summarized. The primary finding of this review is that CholU should be categorized based on the etiology and clinical characteristics of each subtype to properly manage and treat the disease. This categorization leads to improvement of therapeutic resistance status of this disease. In particular, a sweating abnormality should be given more attention when examining patients with CholU. Because CholU is not a homogeneous disease, its subtype classification is important for selection of the most suitable therapeutic method. Further elucidation of the pathophysiology of each subtype is expected.
Collapse
Affiliation(s)
- Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan. .,Department of Dermatology, Division of Medicine for Function and Morphology of Sensory Organs, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569-8686, Japan.
| | - Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Shinya Imamura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Mayuko Mizuno
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Takeshi Fukumoto
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Ken Washio
- Department of Dermatology, Kobe City Nishi-Kobe Medical Center, 5-7-1 Koji-Dai Nishi-ku, Kobe, 651-2273, Japan
| |
Collapse
|
4
|
Tanaka A, Huh JY, Yamamoto T, Washio K, Ariyoshi K. Bowel obstruction secondary to internal hernia in a hereditary angioedema patient: a case report. Int J Emerg Med 2022; 15:69. [PMID: 36585645 PMCID: PMC9805238 DOI: 10.1186/s12245-022-00475-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2022] [Accepted: 12/22/2022] [Indexed: 01/01/2023] Open
Abstract
BACKGROUND Gastrointestinal attacks are frequent symptoms in patients diagnosed with hereditary angioedema (HAE). Cases of self-limited bowel intussusception and unneeded exploratory laparotomy due to lack of knowledge about HAE have been reported. Furthermore, after the introduction of C1-esterase inhibitor (C1-INH) concentrate, the recommended medication for HAE attacks, treatment has become typically medical in nature. We share a rare case where operative exploration was indicated to resolve a mechanical small bowel obstruction secondary to an HAE attack. CASE REPORT An 80-year-old woman with HAE presented with lower left abdominal pain, vomiting, and nausea. Computed tomography (CT) showed edema of the small bowel and stomach as well as possible signs of mechanical small bowel obstruction. The patient was treated with C1-INH concentrate but showed only mild signs of relief, warranting diagnostic laparoscopy. Intraoperative findings showed internal herniation and strangulation of the small bowel caused by adhesions forming a band. After surgical intervention, no bowel resection was needed. CONCLUSION Although C1-INH concentrate remains the principal treatment for HAE, gastrointestinal attacks may potentially cause surgical emergencies.
Collapse
Affiliation(s)
- Atsuhito Tanaka
- grid.410843.a0000 0004 0466 8016Kobe City Medical Center General Hospital, 2-1-1 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo Prefecture 650-0047 Japan
| | - Ji Young Huh
- grid.410843.a0000 0004 0466 8016Kobe City Medical Center General Hospital, 2-1-1 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo Prefecture 650-0047 Japan
| | - Takamasa Yamamoto
- grid.416289.00000 0004 1772 3264Kobe City Nishi-Kobe Medical Center, 5-7-1 Kojidai, Nishi-ku, Kobe, Hyogo Prefecture 651-2273 Japan
| | - Ken Washio
- grid.416289.00000 0004 1772 3264Kobe City Nishi-Kobe Medical Center, 5-7-1 Kojidai, Nishi-ku, Kobe, Hyogo Prefecture 651-2273 Japan
| | - Koichi Ariyoshi
- grid.410843.a0000 0004 0466 8016Kobe City Medical Center General Hospital, 2-1-1 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo Prefecture 650-0047 Japan
| |
Collapse
|
5
|
Mizuno M, Oda Y, Imamura S, Washio K, Fukumoto T, Fukunaga A. IgE receptor responsiveness of basophils in chronic inducible urticaria. Front Immunol 2022; 13:995596. [PMID: 36211415 PMCID: PMC9539802 DOI: 10.3389/fimmu.2022.995596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2022] [Accepted: 09/08/2022] [Indexed: 11/13/2022] Open
Abstract
Introduction Chronic inducible urticaria (CIndU) is a subgroup of chronic urticaria induced by a specific stimulus. We evaluated basophil characteristics in patients with CIndU and compared with those in patients with chronic spontaneous urticaria (CSU) and healthy controls (HCs). Methods Blood was collected from patients, and a basophil activation test (BAT) was performed. Basophil responsiveness and surface marker expression in patients with CIndU were compared with those in patients with CSU and HCs. For some patients with CIndU, blood was collected before and after wheals were induced. In these cases, we compared the responsiveness of basophils before and after the appearance of wheals. Result HCs (n=23) and patients with CIndU (n=24) or CSU (n=38) were enrolled in the study. The degree of basophil activation at steady state in patients with CIndU was higher than in HCs. Basophil responsiveness via high-affinity IgE receptor (FcϵRI) stimulation with anti-IgE or anti-FcϵRI antibody in patients with CIndU was equivalent to that in HCs, and higher than that in patients with CSU. No abnormalities in IgE and FcϵRI expressions on the surface of basophils in patients with CIndU were observed. When we induced wheals in some patients with CIndU and performed a BAT before and after the appearance of wheals, no significant changes were found. Conclusion Peripheral blood basophils in CIndU were slightly activated at steady state, but no abnormalities in basophil responsiveness. In future, a higher number of cases should be enrolled to confirm the role of basophils and refine therapeutic targets for CIndU.
Collapse
Affiliation(s)
- Mayuko Mizuno
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Shinya Imamura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Takeshi Fukumoto
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Atsushi Fukunaga
- Department of Dermatology, Division of Medicine for Function and Morphology of Sensory Organs, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan
- *Correspondence: Atsushi Fukunaga,
| |
Collapse
|
6
|
Kitao R, Oda Y, Washio K, Tai Y, Ono R, Nishigori C, Fukunaga A. Lower efficacy of omalizumab in older adults with chronic spontaneous urticaria. J Dermatol 2022; 49:729-731. [PMID: 35352836 DOI: 10.1111/1346-8138.16370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2021] [Revised: 02/15/2022] [Accepted: 03/13/2022] [Indexed: 11/28/2022]
Abstract
Omalizumab is known to be effective in treating chronic spontaneous urticaria (CSU) with an inadequate response to H1 -antihistamine. Although many reports have described pre-treatment biomarkers to predict the efficacy of omalizumab in CSU, there are few reports that examined the relationship between age and the therapeutic effectiveness of omalizumab. Thus, we aimed to investigate the relationship between response to omalizumab and age. This retrospective study comprised 52 CSU patients receiving three consecutive omalizumab courses during the period from April 2017 to March 2021. Participants were categorized as responders or non/partial responders using the urticaria control test to evaluate clinical variables on week 12. The female rate tended to be higher, and the mean age and the median disease duration tended to be lower with no significance in responders compared with in non/partial responders. In addition, they exhibited no significant differences regarding serum immunoglobulin E levels, basophil counts, eosinophil counts, d-dimer, and autologous serum skin test results reported as predictor in the past between two groups. Interestingly, when patients were categorized as age <65 years or ≥65 years, those in the ≥65 years group had a significantly lower response to omalizumab than those aged <65 years. These findings suggest that physicians should keep in mind that the age of their CSU patients may be a predictor of the therapeutic efficacy of omalizumab.
Collapse
Affiliation(s)
- Rikuma Kitao
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Yukimasa Tai
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Ryusuke Ono
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| |
Collapse
|
7
|
Washio K, Nakamura M, Sato N, Hori M, Matsubara K, Ogura K, Oda Y, Fukunaga A, Yagami A, Matsunaga K. Anaphylaxis in a pectin- and cashew nut-allergic child caused by a citrus bath. Allergol Int 2022; 71:155-157. [PMID: 34353728 DOI: 10.1016/j.alit.2021.07.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2021] [Revised: 06/11/2021] [Accepted: 06/29/2021] [Indexed: 11/26/2022] Open
|
8
|
Matsumoto Y, Imamura S, Fukumoto A, Lee K, Nishitani N, Oda Y, Washio K, Fukunaga A. Case of oral mite anaphylaxis: Contamination of wheat flour by mites determined by enzyme-linked immunosorbent assay. J Dermatol 2021; 49:e59-e60. [PMID: 34796546 DOI: 10.1111/1346-8138.16227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2021] [Revised: 10/07/2021] [Accepted: 10/30/2021] [Indexed: 11/26/2022]
Affiliation(s)
- Yukari Matsumoto
- Department of Dermatology, Nishinomiya Municipal Central Hospital, Nishinomiya, Japan
| | - Shinya Imamura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Ayako Fukumoto
- Department of Dermatology, Nishinomiya Municipal Central Hospital, Nishinomiya, Japan
| | - Kasumi Lee
- Department of Dermatology, Nishinomiya Municipal Central Hospital, Nishinomiya, Japan
| | - Nao Nishitani
- Department of Dermatology, Nishinomiya Municipal Central Hospital, Nishinomiya, Japan
| | - Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| |
Collapse
|
9
|
Ohata M, Oda Y, Washio K, Fukunaga A, Nishigori C. Efficacy of additional treatment for chronic spontaneous urticaria refractory to treatment - A single-center retrospective real-world study. J Dermatol 2021; 49:e7-e8. [PMID: 34632611 DOI: 10.1111/1346-8138.16183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2021] [Revised: 09/17/2021] [Accepted: 09/21/2021] [Indexed: 11/28/2022]
Affiliation(s)
- Marie Ohata
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Ken Washio
- Division of Dermatology, Nishi-Kobe Medical Center, Kobe, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| |
Collapse
|
10
|
Imamura S, Washio K, Mizuno M, Oda Y, Fukunaga A, Nishigori C. Activated steady status and distinctive FcεRI-mediated responsiveness in basophils of atopic dermatitis. Allergol Int 2021; 70:327-334. [PMID: 33674191 DOI: 10.1016/j.alit.2021.01.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2020] [Revised: 12/17/2020] [Accepted: 01/06/2021] [Indexed: 01/03/2023] Open
Abstract
BACKGROUND Although basophils are considered to play an important role for maintenance of type 2 inflammation in atopic dermatitis (AD), studies on basophils in AD patients are limited. Some studies have reported the activation status, including CD203c and CD63, of peripheral blood basophils in AD patients. METHODS We examined the features of circulating basophils in AD patients, assessed cell surface marker expressions and total serum IgE, and compared basophil responsiveness to stimulation between AD patients and healthy controls (HCs). In addition, the correlations among AD severity, laboratory factors, and features of basophils were examined. Blood samples from 38 AD patients and 21 HCs were analyzed. Basophil response markers CD203c and CD63, and expression of surface-bound IgE and FcεRI on basophils were measured. CD203c and CD63 expressions induced by stimulation with anti-IgE and anti-FcεRI antibodies were measured. Clinical/laboratory factors including total serum IgE were examined for correlations with these basophil parameters. RESULTS Baseline CD203c and CD63 expression on basophils were significantly higher in AD patients compared with HCs. The CD203c/CD63 response ratio to anti-FcεRI stimulation was higher than that to anti-IgE stimulation in AD patients, but not HCs. FcεRI expression on basophils was higher in AD patients than in HCs, although surface-bound IgE on basophils was equivalent. Total serum IgE had negative correlations with surface-bound IgE and CD63 responsiveness to anti-IgE stimulation. CONCLUSIONS Basophils were spontaneously activated under steady-state conditions in AD patients and responsiveness to anti-IgE stimulation was lower than in HCs. Despite high serum IgE and high basophil FcεRI expression, surface-bound IgE on basophils remained relatively low. Basophils might be suppressed or exhausted regarding FcεRI signaling via IgE in severe AD.
Collapse
|
11
|
Kumagai J, Nakamura A, Ogawa S, Washio K. Intravaginal metronidazole ovule-related allergic contact dermatitis. Contact Dermatitis 2021; 85:85-86. [PMID: 33423284 DOI: 10.1111/cod.13782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2021] [Accepted: 01/06/2021] [Indexed: 12/01/2022]
Affiliation(s)
- Jun Kumagai
- Department of Dermatology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan
| | - Ayaka Nakamura
- Department of Dermatology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan
| | - Satoshi Ogawa
- Department of Dermatology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan
| | - Ken Washio
- Department of Dermatology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan
| |
Collapse
|
12
|
Oda Y, Washio K, Mizuno M, Imamura S, Nishigori C, Fukunaga A. [HOW PERIPHERAL BASOPHILS IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA ARE CHANGED WITH OMALIZUMAB TREATMENT?]. Arerugi 2021; 70:1196-1199. [PMID: 34759084 DOI: 10.15036/arerugi.70.1196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Affiliation(s)
- Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine
| | - Mayuko Mizuno
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine
| | - Shinya Imamura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine
| |
Collapse
|
13
|
Imamura S, Washio K, Mizuno M, Oda Y, Ogura K, Fukunaga A, Nishigori C. A case of atopic dermatitis with hypohidrosis improved after dupilumab treatment. J Cutan Immunol Allergy 2020. [DOI: 10.1002/cia2.12142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Affiliation(s)
- Shinya Imamura
- Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine 7‐5‐1 Kusunoki‐cho, Chuo‐ku Kobe650‐0017Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine 7‐5‐1 Kusunoki‐cho, Chuo‐ku Kobe650‐0017Japan
| | - Mayuko Mizuno
- Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine 7‐5‐1 Kusunoki‐cho, Chuo‐ku Kobe650‐0017Japan
| | - Yoshiko Oda
- Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine 7‐5‐1 Kusunoki‐cho, Chuo‐ku Kobe650‐0017Japan
| | - Kanako Ogura
- Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine 7‐5‐1 Kusunoki‐cho, Chuo‐ku Kobe650‐0017Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine 7‐5‐1 Kusunoki‐cho, Chuo‐ku Kobe650‐0017Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine 7‐5‐1 Kusunoki‐cho, Chuo‐ku Kobe650‐0017Japan
| |
Collapse
|
14
|
Oda Y, Fukunaga A, Washio K, Imamura S, Mizuno M, Hatakeyama M, Ogura K, Nishigori C. Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria. J Allergy Clin Immunol Pract 2020; 9:1166-1176.e8. [PMID: 32898709 DOI: 10.1016/j.jaip.2020.08.048] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/04/2020] [Revised: 07/30/2020] [Accepted: 08/20/2020] [Indexed: 11/15/2022]
Abstract
BACKGROUND Omalizumab is effective in patients with chronic spontaneous urticaria (CSU) although its mechanism of action is poorly understood. Several studies reported that decreased high-affinity IgE receptor (FcεRI)-mediated histamine release and/or responsiveness was characteristic of basophils in patients with CSU. However, few studies have focused on the relationship between changes in basophil responsiveness via FcεRI after omalizumab treatment and the therapeutic effect in patients with CSU. OBJECTIVE To assess basophil responsiveness via FcεRI stimulation, as well as FcεRI expression and IgE binding on blood basophils from patients with CSU before and after omalizumab treatment and its possible association with the clinical response. METHODS We analyzed 34 patients with CSU treated with omalizumab who were categorized as fast responders (FRs) (n = 20) and non or slow responders (N/SRs) (n = 14). CD203c expression induced by FcεRI stimulation, and IgE and FcεRI expressions on blood basophils from patients with CSU before and after omalizumab treatment were analyzed. Basophil responsiveness via FcεRI stimulation was observed in vitro using basophils pretreated with omalizumab. RESULTS FRs had increased CD203c responsiveness after treatment with omalizumab compared with N/SRs. This improvement of basophil responsiveness via FcεRI stimulation in FRs was not observed in peripheral blood basophils preincubated with omalizumab in vitro, suggesting that omalizumab does not directly affect circulating pre-existing abnormal basophils. CONCLUSION Increased basophil responsiveness via FcεRI after omalizumab treatment is associated with the therapeutic effect and mechanism of action of omalizumab.
Collapse
Affiliation(s)
- Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan.
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Shinya Imamura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Mayuko Mizuno
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Mayumi Hatakeyama
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Kanako Ogura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| |
Collapse
|
15
|
Nishimura T, Saito Y, Washio K, Komori S, Respatika D, Kotani T, Murata Y, Ohnishi H, Mizobuchi S, Matozaki T. SIRPα on CD11c + cells induces Th17 cell differentiation and subsequent inflammation in the CNS in experimental autoimmune encephalomyelitis. Eur J Immunol 2020; 50:1560-1570. [PMID: 32438469 DOI: 10.1002/eji.201948410] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2019] [Revised: 04/12/2020] [Indexed: 01/06/2023]
Abstract
Signal regulatory protein α (SIRPα) is expressed predominantly on type 2 conventional dendritic cells (cDC2s) and macrophages. We previously showed that mice systemically lacking SIRPα were resistant to experimental autoimmune encephalomyelitis (EAE). Here, we showed that deletion of SIRPα in CD11c+ cells of mice (SirpaΔDC mice) also markedly ameliorated the development of EAE. The frequency of cDCs and migratory DCs (mDCs), as well as that of Th17 cells, were significantly reduced in draining lymph nodes of SirpaΔDC mice at the onset of EAE. In addition, we found the marked reduction in the number of Th17 cells and DCs in the CNS of SirpaΔDC mice at the peak of EAE. Whereas inducible systemic ablation of SIRPα before the induction of EAE prevented disease development, that after EAE onset did not ameliorate the clinical signs of disease. We also found that EAE development was partially attenuated in mice with CD11c+ cell-specific ablation of CD47, a ligand of SIRPα. Collectively, our results suggest that SIRPα expressed on CD11c+ cells, such as cDC2s and mDCs, is indispensable for the development of EAE, being required for the priming of self-reactive Th17 cells in the periphery as well as for the inflammation in the CNS.
Collapse
Affiliation(s)
- Taichi Nishimura
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.,Division of Anesthesiology, Department of Surgery Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Yasuyuki Saito
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Ken Washio
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Satomi Komori
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Datu Respatika
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.,Division of Reconstruction, Oculoplasty, and Oncology, Department of Ophthalmology, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University, Yogyakarta, Indonesia
| | - Takenori Kotani
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Yoji Murata
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Hiroshi Ohnishi
- Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Gunma, Japan
| | - Satoshi Mizobuchi
- Division of Anesthesiology, Department of Surgery Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Takashi Matozaki
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| |
Collapse
|
16
|
Fujiwara S, Nakano E, Nakamura K, Washio K, Ogura K, Nishigori C. Pazopanib as a potential chemotherapy for cutaneous angiosarcoma: A case series of 10 patients from a single institution. J Dermatol 2020; 47:e273-e274. [PMID: 32399986 DOI: 10.1111/1346-8138.15381] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Susumu Fujiwara
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Eiji Nakano
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Korefumi Nakamura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Kanako Ogura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| |
Collapse
|
17
|
Oda Y, Washio K, Fukunaga A, Mizuno M, Hirai H, Imamura S, Hatakeyama M, Ogura K, Nishigori C. Establishment of the basophil activation test to detect photoallergens in solar urticaria. J Allergy Clin Immunol Pract 2020; 8:2817-2819.e1. [PMID: 32348909 DOI: 10.1016/j.jaip.2020.04.042] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2020] [Revised: 04/17/2020] [Accepted: 04/17/2020] [Indexed: 10/24/2022]
Affiliation(s)
- Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kusunoki-cho, Chuo-ku, Kobe, Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kusunoki-cho, Chuo-ku, Kobe, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kusunoki-cho, Chuo-ku, Kobe, Japan.
| | - Mayuko Mizuno
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kusunoki-cho, Chuo-ku, Kobe, Japan
| | - Hiroyuki Hirai
- Advanced Technology and Development Division, BML, Inc, Matoba, Kawagoe-shi, Saitama, Japan
| | - Shinya Imamura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kusunoki-cho, Chuo-ku, Kobe, Japan
| | - Mayumi Hatakeyama
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kusunoki-cho, Chuo-ku, Kobe, Japan
| | - Kanako Ogura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kusunoki-cho, Chuo-ku, Kobe, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kusunoki-cho, Chuo-ku, Kobe, Japan
| |
Collapse
|
18
|
Mizuno M, Fukunaga A, Washio K, Imamura S, Oda Y, Nishigori C. A visual analogue scale for itch and pain in 23 cases of cholinergic urticaria. J Eur Acad Dermatol Venereol 2020; 34:e493-e495. [PMID: 32242985 DOI: 10.1111/jdv.16410] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2019] [Revised: 02/12/2020] [Accepted: 03/17/2020] [Indexed: 12/15/2022]
Affiliation(s)
- M Mizuno
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - A Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - K Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - S Imamura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Y Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - C Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| |
Collapse
|
19
|
Oda Y, Washio K, Fukunaga A, Imamura S, Hatakeyama M, Ogura K, Ishii K, Hide M, Nishigori C. Clinical utility of the basophil activation test in the diagnosis of sweat allergy. Allergol Int 2020; 69:261-267. [PMID: 31615718 DOI: 10.1016/j.alit.2019.09.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2019] [Revised: 08/26/2019] [Accepted: 09/12/2019] [Indexed: 11/24/2022] Open
Abstract
BACKGROUND Many patients with atopic dermatitis and cholinergic urticaria display an immediate-type allergy to autologous sweat. Although the histamine release test (HRT) using semi-purified sweat antigen (QR) was available for the detection of immediate sweat allergy, the existence of HRT low responders could not be disregarded. Furthermore, it has not been established whether the results of the HRT are consistent with the autologous sweat skin test (ASwST). We aimed to compare the HRT and basophil activation test (BAT) for the diagnosis of immediate sweat allergy. METHODS The HRT and BAT were performed on 47 subjects (35 ASwST positive, 12 negative) whose symptoms had worsened on sweating. For the BAT, blood was incubated with QR or crude sweat and CD203c upregulation was assessed. A commercial HRT was performed and histamine release induced by QR was quantified. RESULTS When excluding non-responders for anti-IgE antibody, the BAT using QR and the HRT had a sensitivity of 100% and 44% and specificity of 75% and 100%, respectively. The BAT and HRT had a positive predictive value of 91.3% and 100% and negative predictive value of 100% and 30%, respectively. The BAT detected 0% non-responders, whereas the HRT identified 22.5%. When using crude sweat for the BAT, the false-positives observed when using QR were not detected. CONCLUSIONS The BAT using QR displayed a higher sensitivity and negative predictive value and a lower number of non-responders compared with the HRT. Furthermore, the BAT using crude sweat can also be an alternative tool for the ASwST.
Collapse
|
20
|
Oda Y, Fukunaga A, Washio K, Imamura S, Nishigori C. Reply. J Allergy Clin Immunol Pract 2020; 8:826-827. [PMID: 32037121 DOI: 10.1016/j.jaip.2019.11.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/27/2019] [Accepted: 11/28/2019] [Indexed: 11/26/2022]
Affiliation(s)
- Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Shinya Imamura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan
| |
Collapse
|
21
|
Fukunaga A, Oda Y, Washio K, Omori T, Kakei Y, Hide M, Nishigori C. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial. Trials 2020; 21:23. [PMID: 31906999 PMCID: PMC6945582 DOI: 10.1186/s13063-019-3878-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2019] [Accepted: 11/04/2019] [Indexed: 01/19/2023] Open
Abstract
BACKGROUND Chronic spontaneous urticaria (CSU) is characterized by the spontaneous appearance of wheals, angioedema, or both for > 6 weeks. Continuous treatment with H1-antihistamines is used as a first-line treatment for CSU. However, H1-antihistamine treatment leads to absence of symptoms in less than 50% of patients with CSU. Although Japanese guidelines for the diagnosis and treatment of urticaria recommend an increase in the H1-antihistamine dose or a switch to other H1-antihistamines, there is no evidence supporting a switch to other H1-antihistamines in patients with refractory CSU who are unresponsive to H1-antihistamines at the licensed dose. METHODS We will conduct a multicenter, open-label, non-inferiority, randomized, parallel, comparison study to determine if the efficacy of bilastine 20 mg is not inferior to that of a twofold H1-antihistamine dose increase in patients with refractory CSU who are unresponsive to H1-antihistamines at the licensed dose. This study will be performed at 15 academic hospitals in Japan, and the administration period (increasing the H1-antihistamine dose twofold vs. switching to bilastine 20 mg) will be 7 days. Participants (n = 150) will be randomized to either an increased H1-antihistamine dose or a switch to bilastine 20 mg at a 1:1 ratio. The primary endpoint, mean of the total symptom score of 5-7 days after the intervention, will be evaluated. The secondary objective is to determine if the safety of bilastine 20 mg regarding somnolence is superior to that of a twofold dose increase of H1-antihistamines. This will be measured by a change in the Japanese version of the Epworth Sleepiness Scale from baseline to 7 days after starting the intervention. DISCUSSION This multicenter, open-label, non-inferiority, randomized, parallel, comparison study will be, to our knowledge, the first well-designed clinical study to evaluate the efficacy of a switch to other H1-antihistamines in patients with refractory CSU who are unresponsive to H1-antihistamines at the licensed doses. This trial will provide evidence of the efficacy and safety of bilastine when treatment is switched in patients with refractory CSU who are unresponsive to H1-antihistamines at the licensed dose. TRIAL REGISTRATION Japan Registry of Clinical Trials (jRCT), jRCTs051180105. Registered on 8 March 2019.
Collapse
Affiliation(s)
- Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
| | - Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
| | - Takashi Omori
- Division of Biostatistics, Department of Social/Community Medicine and Health Science, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Yasumasa Kakei
- Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Michihiro Hide
- Department of Dermatology, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
| |
Collapse
|
22
|
Oda Y, Fukunaga A, Washio K, Imamura S, Hatakeyama M, Ogura K, Nishigori C. Low Responsiveness of Basophils via FcεRI Reflects Disease Activity in Chronic Spontaneous Urticaria. The Journal of Allergy and Clinical Immunology: In Practice 2019; 7:2835-2844.e7. [DOI: 10.1016/j.jaip.2019.05.020] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/04/2019] [Revised: 05/10/2019] [Accepted: 05/17/2019] [Indexed: 11/24/2022]
|
23
|
Nakatani S, Oda Y, Washio K, Fukunaga A, Nishigori C. The Urticaria Control Test and Urticaria Activity Score correlate with quality of life in adult Japanese patients with chronic spontaneous urticaria. Allergol Int 2019; 68:279-281. [PMID: 30527936 DOI: 10.1016/j.alit.2018.11.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2018] [Revised: 10/29/2018] [Accepted: 10/30/2018] [Indexed: 10/27/2022] Open
|
24
|
Shinkawa E, Washio K, Tatsuoka S, Fukunaga A, Sakaguchi K, Nishigori C. A case of contact dermatitis caused by isobornyl acrylate in FreeStyle Libre: The usefulness of film‐forming agents. Contact Dermatitis 2019; 81:56-57. [DOI: 10.1111/cod.13239] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2019] [Revised: 01/31/2019] [Accepted: 02/04/2019] [Indexed: 11/27/2022]
Affiliation(s)
- Eriko Shinkawa
- Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine Kobe Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine Kobe Japan
| | - Saori Tatsuoka
- Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine Kobe Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine Kobe Japan
| | - Kazuhiko Sakaguchi
- Division of Diabetes and Endocrinology, Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine Kobe Japan
| |
Collapse
|
25
|
Chayahara N, Mukohara T, Tachihara M, Fujishima Y, Fukunaga A, Washio K, Yamamoto M, Nakata K, Kobayashi K, Takenaka K, Toyoda M, Kiyota N, Tobimatsu K, Doi H, Mizuta N, Marugami N, Kawaguchi A, Nishigori C, Nishimura Y, Minami H. Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE). Oncologist 2019; 24:885-e413. [PMID: 30890624 PMCID: PMC6656472 DOI: 10.1634/theoncologist.2019-0156] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2019] [Accepted: 02/18/2019] [Indexed: 11/17/2022] Open
Abstract
LESSONS LEARNED The results of the APPEARANCE trial indicate that adapalene does not prevent acne-like rash over placebo when added to topical moisturizer and oral minocycline but instead may have a detrimental effect. Therefore, adapalene is not recommended as prophylaxis against acne-like rash induced by anti-epidermal growth factor receptor therapies.Given that acne-like rash was completely controlled with placebo in approximately half of patients, predictive measures to identify patients needing intensive prophylaxis are required. BACKGROUND Anti-epidermal growth factor receptor (EGFR) therapies are frequently associated with acne-like rash. To evaluate the prophylactic efficacy of adapalene, a topical retinoid used as first-line therapy for acne vulgaris, we conducted a randomized, placebo-controlled, evaluator-blinded, left-right comparative trial. METHODS Patients with non-small cell lung, colorectal, or head and neck cancer scheduled to receive anti-EGFR therapies were randomly assigned to once-daily adapalene application on one side of the face, with placebo on the other side. All patients had topical moisturizer coapplied to both sides of the face, and received oral minocycline. The primary endpoint was the difference in total facial lesion count of acne-like rash at 4 weeks. Secondary endpoints included complete control rate (CCR) of acne-like rash (≤5 facial lesions) and global skin assessment (Investigator's Global Assessment [IGA] scale, grade 0-4) at 4 weeks. Two blinded dermatologists independently evaluated the endpoints from photographs. RESULTS A total of 36 patients were enrolled, of whom 26 were evaluable. Adapalene treatment was associated with a greater lesion count than placebo at 4 weeks, although the difference was not statistically significant (mean, 12.6 vs. 9.8, p = .12). All four patients with a difference >10 in lesion count between face sides had a greater count on the adapalene-treated side. No significant differences were observed in CCR of acne-like rash (54% vs. 50%) or IGA scale (mean grade, 1.9 vs. 1.7) between the adapalene and placebo sides. CONCLUSION Adapalene is not recommended as prophylaxis against acne-like rash induced by anti-EGFR therapies.
Collapse
Affiliation(s)
- Naoko Chayahara
- Division of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Toru Mukohara
- Division of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan
- Division of Cancer Center, Kobe University Hospital, Kobe, Japan
| | - Motoko Tachihara
- Division of Respiratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Yoshimi Fujishima
- Division of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan
- Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Masatsugu Yamamoto
- Division of Respiratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Kyosuke Nakata
- Division of Respiratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Kazuyuki Kobayashi
- Division of Respiratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Kei Takenaka
- Division of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Masanori Toyoda
- Division of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Naomi Kiyota
- Division of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan
- Division of Cancer Center, Kobe University Hospital, Kobe, Japan
| | - Kazutoshi Tobimatsu
- Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Hisayo Doi
- Department of Nursing, Kobe University Hospital, Kobe, Japan
| | - Naomi Mizuta
- Department of Hospital Pharmacy, Kobe University Hospital, Kobe, Japan
| | - Naho Marugami
- Department of Hospital Pharmacy, Kobe University Hospital, Kobe, Japan
| | - Atsushi Kawaguchi
- Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Yoshihiro Nishimura
- Division of Respiratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Hironobu Minami
- Division of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan
- Division of Cancer Center, Kobe University Hospital, Kobe, Japan
| |
Collapse
|
26
|
Fujii S, Washio K, Masaki T. Case report of chronic actinic dermatitis accompanied by ultraviolet A photosensitivity in a Chrysanthemum farmer. J Dermatol 2019; 46:e229-e230. [PMID: 30811065 DOI: 10.1111/1346-8138.14818] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- Shotaro Fujii
- Department of Dermatology, Kobe-City Nishi Kobe Medical Center, Hyogo, Japan
| | - Ken Washio
- Department of Dermatology, Kobe-City Nishi Kobe Medical Center, Hyogo, Japan.,Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Hyogo, Japan
| | - Taro Masaki
- Department of Dermatology, Kobe-City Nishi Kobe Medical Center, Hyogo, Japan
| |
Collapse
|
27
|
Fukunaga A, Tsuchiyama S, Lee K, Washio K, Hashimura C, Horiuchi T, Nishigori C. The relationship between complement levels and disease activity in Japanese family cases of hereditary angioedema with C1-INH deficiency. Allergol Int 2018; 67:518-520. [PMID: 29661499 DOI: 10.1016/j.alit.2018.03.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2017] [Revised: 02/26/2018] [Accepted: 03/08/2018] [Indexed: 10/17/2022] Open
|
28
|
Murase C, Takeichi T, Shibata A, Nakatochi M, Kinoshita F, Kubo A, Nakajima K, Ishii N, Amano H, Masuda K, Kawakami H, Kanekura T, Washio K, Asano M, Teramura K, Akasaka E, Tohyama M, Hatano Y, Ochiai T, Moriwaki S, Sato T, Ishida-Yamamoto A, Seishima M, Kurosawa M, Ikeda S, Akiyama M. Cross-sectional survey on disease severity in Japanese patients with harlequin ichthyosis/ichthyosis: Syndromic forms and quality-of-life analysis in a subgroup. J Dermatol Sci 2018; 92:127-133. [PMID: 30241690 DOI: 10.1016/j.jdermsci.2018.08.008] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2018] [Revised: 08/16/2018] [Accepted: 08/26/2018] [Indexed: 11/29/2022]
Abstract
BACKGROUND Congenital ichthyoses (CIs) adversely affect quality of life (QOL) in patients. However, the effects of CIs on patient QOL have not been studied sufficiently. OBJECTIVE To investigate the association between disease severity and QOL in patients with harlequin ichthyosis (HI) and ichthyosis: syndromic forms (ISFs) METHODS: Clinical information of patients with HI and ISFs from 2010 to 2015 were obtained from 100 dermatology departments/divisions of principal institutes/hospitals throughout Japan. We examined the relationship between disease severity and QOL in patients with HI and ISFs. Patients who were aged 8 years or older and participated in a multicenter retrospective questionnaire survey in Japan were assessed by dermatology life quality index (DLQI, range of 0-30) and clinical ichthyosis score (range of 0-100). RESULTS Netherton syndrome patients had a significantly higher risk of allergy to food or environmental allergens than patients with other phenotypes. Keratitis-ichthyosis-deafness (KID) syndrome patients showed a significantly higher risk of skin infections than patients with other phenotypes. Complete data on DLQI were obtained from 13 patients, whose median age was 21 (8-71) years. Nine patients were male, and 4 were female. Systemic retinoids were administrated to 2 of the 3 HI patients. The Spearman's correlation coefficient between the clinical ichthyosis score and DLQI was 0.611 (P < 0.05). CONCLUSION We confirmed that Netherton syndrome and KID syndrome patients have a higher risk of allergy to food or environmental allergens and of skin infections, respectively. QOL impairment correlates with disease severity in HI and ISFs patients.
Collapse
Affiliation(s)
- Chiaki Murase
- Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan
| | - Takuya Takeichi
- Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan
| | - Akitaka Shibata
- Department of Dermatology, Gifu Prefectural Tajimi Hospital, 161-5 Maehata-cho, Tajimi 507-8522, Japan
| | - Masahiro Nakatochi
- Statistical Analysis Section, Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan
| | - Fumie Kinoshita
- Statistical Analysis Section, Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan
| | - Akiharu Kubo
- Department of Dermatology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan
| | - Kimiko Nakajima
- Department of Dermatology, Kochi Medical School, 185-1 Kohasu, Okoh-cho, Nanakoku, Kochi 783-8505, Japan
| | - Norito Ishii
- Department of Dermatology, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka 830-0011, Japan
| | - Hiroo Amano
- Department of Dermatology, Iwate Medical University School of Medicine, 19-1 Uchimaru, Morioka, Iwate 020-8505, Japan
| | - Koji Masuda
- Department of Dermatology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan
| | - Hiroshi Kawakami
- Department of Dermatology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan
| | - Takuro Kanekura
- Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-shi, Kagoshima 890-8520, Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
| | - Masayuki Asano
- Department of Dermatology, Tohoku University Graduate School of Medicine, Seiryoumachi 1-1, Aoba-ku, Sendai 980-8574, Japan
| | - Kazuya Teramura
- Department of Dermatology, Shiga University of Medical Science, Setatsukinowa-cho, Otsu, Shiga 520-2192, Japan
| | - Eijiro Akasaka
- Department of Dermatology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki 036-8562, Japan
| | - Mikiko Tohyama
- Department of Dermatology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon-shi, Ehime 791-0295, Japan
| | - Yutaka Hatano
- Department of Dermatology, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita 879-5593, Japan
| | - Toyoko Ochiai
- Department of Dermatology, Nihon University Hospital, 1-6 Kanda Surugadai, Chiyoda-Ku, Tokyo, 101-8309, Japan
| | - Shinichi Moriwaki
- Department of Dermatology, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, Japan
| | - Tomotaka Sato
- Department of Dermatology, Teikyo University Chiba Medical Center, 3426-3 Anesaki, Ichihara 299-0111, Japan
| | - Akemi Ishida-Yamamoto
- Department of Dermatology, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahi-kawa, Hokkaido 078-8510, Japan
| | - Mariko Seishima
- Department of Dermatology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu-shi, Gifu 501-1194, Japan
| | - Michiko Kurosawa
- Departments of Epidemiology and Environmental Health, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
| | - Shigaku Ikeda
- Departments of Dermatology, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
| | - Masashi Akiyama
- Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.
| |
Collapse
|
29
|
Affiliation(s)
- Ken Washio
- Department of Dermatology, Kobe-City Nishi Kobe Medical Center, Hyogo, Japan; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Hyogo, Japan.
| | - Taro Masaki
- Department of Dermatology, Kobe-City Nishi Kobe Medical Center, Hyogo, Japan; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Hyogo, Japan
| | - Shotaro Fujii
- Department of Dermatology, Kobe-City Nishi Kobe Medical Center, Hyogo, Japan
| | - Mayumi Hatakeyama
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Hyogo, Japan
| | - Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Hyogo, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Hyogo, Japan
| | - Masaru Natsuaki
- Department of Dermatology, Hyogo College of Medicine, Hyogo, Japan
| |
Collapse
|
30
|
Tachihara M, Chayahara N, Fujishima Y, Fukunaga A, Washio K, Yamamoto M, Nakata K, Kobayashi K, Takenaka K, Toyoda M, Kiyota N, Tobimatsu K, Doi H, Mizuta N, Marugami N, Kawaguchi A, Nishigori C, Nishimura Y, Mukohara T, Minami H. Adapalene gel 0.1% vs. placebo as prophylaxis for anti-EGFR-induced acne-like rash: A randomized left-right comparative evaluation (APPEARANCE). J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.10093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Motoko Tachihara
- Divisions of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Naoko Chayahara
- Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
| | - Yoshimi Fujishima
- DIvision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Masatsugu Yamamoto
- Divisions of Respiratory Medicine, Kobe University Graduate School of Medicine., Kobe, Japan
| | - Kyosuke Nakata
- Divisions of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Kazuyuki Kobayashi
- Divisions of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Kei Takenaka
- Division of Medical Oncology/Hematology, Kobe University Hospital, Kobe, Japan
| | - Masanori Toyoda
- Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan
| | - Naomi Kiyota
- Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
| | | | - Hisayo Doi
- Department of Nursing, Kobe University Hospital, Kobe, Japan
| | - Naomi Mizuta
- Hospital Pharmacy, Kobe University Hospital, Kobe, Japan
| | - Naho Marugami
- Hospital Pharmacy, Kobe University Hospital, Kobe, Japan
| | - Atsushi Kawaguchi
- Center for Comprehensive Community Medicine, Faculty of Medicine, Saga University, Saga, Japan
| | - Chikako Nishigori
- Division of Dermatology, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Yoshihiro Nishimura
- Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Toru Mukohara
- Cancer Center, Kobe University Hospital, Kobe, Japan
| | - Hironobu Minami
- Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan
| |
Collapse
|
31
|
Washio K, Yamamoto G, Ikemachi M, Fujii S, Ohnuma K, Masaki T. Rhabdomyolysis due to bacteremia from Enterobacter cowanii caused by a rose thorn prick. J Dermatol 2018; 45:e313-e314. [PMID: 29696688 DOI: 10.1111/1346-8138.14341] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Ken Washio
- Department of Dermatology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan
| | - Go Yamamoto
- Department of Clinical Laboratory, Kobe City Nishi-Kobe Medical Center, Kobe, Japan
| | - Mami Ikemachi
- Department of Clinical Laboratory, Kobe City Nishi-Kobe Medical Center, Kobe, Japan
| | - Shotaro Fujii
- Department of Dermatology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan
| | - Kenichiro Ohnuma
- Department of Clinical Laboratory, Kobe University Hospital, Kobe, Japan
| | - Taro Masaki
- Department of Dermatology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan
| |
Collapse
|
32
|
Aoe M, Ishida H, Matsubara T, Karakawa S, Kawaguchi H, Fujiwara K, Kanamitsu K, Washio K, Okada K, Shibakura M, Shimada A. Simultaneous detection of ABL1
mutation and IKZF1
deletion in Philadelphia chromosome-positive acute lymphoblastic leukemia using a customized target enrichment system panel. Int J Lab Hematol 2018; 40:427-436. [DOI: 10.1111/ijlh.12805] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2017] [Accepted: 02/15/2018] [Indexed: 11/30/2022]
Affiliation(s)
- M. Aoe
- Division of Medical Support; Okayama University Hospital; Okayama Japan
| | - H. Ishida
- Department of Pediatrics; Okayama University Hospital; Okayama Japan
| | - T. Matsubara
- Department of BioBank; Okayama University Hospital; Okayama Japan
| | - S. Karakawa
- Department of Pediatrics; Hiroshima University Hospital; Hiroshima Japan
| | - H. Kawaguchi
- Department of Pediatrics; Hiroshima University Hospital; Hiroshima Japan
| | - K. Fujiwara
- Department of Pediatrics; Okayama University Hospital; Okayama Japan
| | - K. Kanamitsu
- Department of Pediatrics; Okayama University Hospital; Okayama Japan
| | - K. Washio
- Department of Pediatrics; Okayama University Hospital; Okayama Japan
| | - K. Okada
- Division of Medical Support; Okayama University Hospital; Okayama Japan
| | - M. Shibakura
- Field of Medical Technology; Okayama University Graduate School of Health Sciences; Okayama Japan
| | - A. Shimada
- Department of Pediatrics; Okayama University Hospital; Okayama Japan
| |
Collapse
|
33
|
Hatakeyama M, Fukunaga A, Washio K, Taguchi K, Oda Y, Ogura K, Nishigori C. Anti-Inflammatory Role of Langerhans Cells and Apoptotic Keratinocytes in Ultraviolet-B-Induced Cutaneous Inflammation. J Immunol 2017; 199:2937-2947. [PMID: 28893957 DOI: 10.4049/jimmunol.1601681] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/30/2016] [Accepted: 08/14/2017] [Indexed: 02/03/2023]
Abstract
UV radiation, particularly UVB, is the major risk factor for the induction of skin cancer, and it induces skin inflammation and immunosuppression. Although reports documented that Langerhans cells (LCs) play various roles in photobiology, little is known about whether they contribute to UVB-induced cutaneous inflammation. Recently, the anti-inflammatory effect of apoptotic cells was noted. This study focuses on the roles of LCs and apoptotic cells in UVB-induced cutaneous inflammation. We show that LCs are essential for resolution of UVB-induced cutaneous inflammation. Administration of quinolyl-valyl-O-methylaspartyl-[2,6-difluophenoxy]-methyl ketone, a broad-spectrum caspase inhibitor with potent antiapoptotic properties, inhibited the formation of UVB-induced apoptotic cells and aggravated UVB-induced cutaneous inflammation in wild-type mice. In contrast, exacerbation of UVB-induced cutaneous inflammation following quinolyl-valyl-O-methylaspartyl-[2,6-difluophenoxy]-methyl ketone administration was not observed in LC-depleted mice. These results suggest that the interaction between LCs and apoptotic cells is critical for resolution of UVB-induced cutaneous inflammation. Interestingly, UVB-induced apoptotic keratinocytes were increased in LC-depleted mice. In addition, we revealed that UVB-induced apoptotic keratinocytes were phagocytosed by LCs ex vivo and that prolongation of UVB-induced cutaneous inflammation following treatment with Cytochalasin D, an inhibitor of phagocytosis, was partially attenuated in LC-depleted mice. Collectively, our findings demonstrate that the interaction between LCs and apoptotic cells, possibly via LC-mediated phagocytosis of apoptotic keratinocytes, has an essential anti-inflammatory role in the resolution of UVB-induced cutaneous inflammation.
Collapse
Affiliation(s)
- Mayumi Hatakeyama
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan
| | - Kumiko Taguchi
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan
| | - Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan
| | - Kanako Ogura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan
| |
Collapse
|
34
|
Washio K, Ijuin K, Fukunaga A, Nagai H, Nishigori C. Contact anaphylaxis caused by Basic Blue 99 in hair dye. Contact Dermatitis 2017; 77:122-123. [DOI: 10.1111/cod.12740] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2016] [Revised: 11/10/2016] [Accepted: 11/10/2016] [Indexed: 11/29/2022]
Affiliation(s)
- Ken Washio
- Department of Dermatology; Nishi Kobe Medical Centre; Kobe 651-2273 Japan
- Division of Dermatology, Department of Internal Related; Kobe University Graduate School of Medicine; Kobe 650-0017 Japan
| | - Keiko Ijuin
- Division of Dermatology, Department of Internal Related; Kobe University Graduate School of Medicine; Kobe 650-0017 Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related; Kobe University Graduate School of Medicine; Kobe 650-0017 Japan
| | - Hiroshi Nagai
- Division of Dermatology, Department of Internal Related; Kobe University Graduate School of Medicine; Kobe 650-0017 Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related; Kobe University Graduate School of Medicine; Kobe 650-0017 Japan
| |
Collapse
|
35
|
Fukunaga A, Washio K, Hatakeyama M, Oda Y, Ogura K, Horikawa T, Nishigori C. Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management. Clin Auton Res 2017; 28:103-113. [PMID: 28382552 DOI: 10.1007/s10286-017-0418-6] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2017] [Accepted: 03/29/2017] [Indexed: 11/26/2022]
Abstract
PURPOSE The aim of this study was to review the evidence on the epidemiology, physiopathology, categorization, and management of cholinergic urticaria. We specifically focused on several subtypes of cholinergic urticaria and investigated the relationship between cholinergic urticaria and idiopathic anhidrosis. METHODS Using an integrative approach, we reviewed publications addressing the epidemiology, clinical features, diagnostic approach, physiopathology, subtype classification, and therapeutic approach to cholinergic urticaria. RESULTS Multiple mechanisms were found to contribute to the development of cholinergic urticaria. This disorder should be classified based on the pathogenesis and clinical characteristics of each subtype. Such a classification system would lead to better management of this resistant condition. In particular, sweating function should be given more attention when examining patients with cholinergic urticaria. CONCLUSIONS Because cholinergic urticaria is not a homogeneous disease, its subtype classification is essential for selection of the most suitable therapeutic method.
Collapse
Affiliation(s)
- Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
- Division of Dermatology, Nishi-Kobe Medical Center, 5-7-1 Koji-Dai, Nishi-ku, Kobe, 651-2273, Japan
| | - Mayumi Hatakeyama
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
| | - Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
| | - Kanako Ogura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
| | - Tatsuya Horikawa
- Ueda Dermatology Clinic, 1654-5 Harima-cho Nozoe, Nishi-ku, Kako-Gun, 675-0151, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
| |
Collapse
|
36
|
Washio K, Sumi M, Nakata K, Fukunaga A, Yamana K, Koda T, Morioka I, Nishigori C, Yamanishi K. Case of harlequin ichthyosis with a favorable outcome: Early treatment and novel, differentially expressed, alternatively spliced transcripts of the ATP-binding cassette subfamily A member 12 gene. J Dermatol 2017; 44:950-953. [DOI: 10.1111/1346-8138.13823] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2016] [Accepted: 02/01/2017] [Indexed: 12/01/2022]
Affiliation(s)
- Ken Washio
- Division of Dermatology; Nishi-Kobe Medical Center; Kobe Japan
- Division of Dermatology; Department of Internal Related; Kobe University Graduate School of Medicine; Kobe Japan
| | - Mayuko Sumi
- Division of Dermatology; Department of Internal Related; Kobe University Graduate School of Medicine; Kobe Japan
| | - Kaori Nakata
- Division of Dermatology; Department of Internal Related; Kobe University Graduate School of Medicine; Kobe Japan
| | - Atsushi Fukunaga
- Division of Dermatology; Department of Internal Related; Kobe University Graduate School of Medicine; Kobe Japan
| | - Keiji Yamana
- Division of Pediatrics; Department of Internal Related; Kobe University Graduate School of Medicine; Kobe Japan
| | - Tsubasa Koda
- Division of Pediatrics; Department of Internal Related; Kobe University Graduate School of Medicine; Kobe Japan
| | - Ichiro Morioka
- Division of Pediatrics; Department of Internal Related; Kobe University Graduate School of Medicine; Kobe Japan
| | - Chikako Nishigori
- Division of Dermatology; Department of Internal Related; Kobe University Graduate School of Medicine; Kobe Japan
| | | |
Collapse
|
37
|
Washio K, Fukunaga A, Onodera M, Hatakeyama M, Taguchi K, Ogura K, Horikawa T, Nishigori C. Clinical characteristics in cholinergic urticaria with palpebral angioedema: Report of 15 cases. J Dermatol Sci 2017; 85:135-137. [DOI: 10.1016/j.jdermsci.2016.11.001] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2016] [Revised: 10/24/2016] [Accepted: 11/07/2016] [Indexed: 11/15/2022]
|
38
|
Yanagita T, Murata Y, Tanaka D, Motegi SI, Arai E, Daniwijaya EW, Hazama D, Washio K, Saito Y, Kotani T, Ohnishi H, Oldenborg PA, Garcia NV, Miyasaka M, Ishikawa O, Kanai Y, Komori T, Matozaki T. Anti-SIRP α antibodies as a potential new tool for cancer immunotherapy. JCI Insight 2017; 2:e89140. [PMID: 28097229 DOI: 10.1172/jci.insight.89140] [Citation(s) in RCA: 105] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Tumor cells are thought to evade immune surveillance through interaction with immune cells. Much recent attention has focused on the modification of immune responses as a basis for new cancer treatments. SIRPα is an Ig superfamily protein that inhibits phagocytosis in macrophages upon interaction with its ligand CD47 expressed on the surface of target cells. Here, we show that SIRPα is highly expressed in human renal cell carcinoma and melanoma. Furthermore, an anti-SIRPα Ab that blocks the interaction with CD47 markedly suppressed tumor formation by renal cell carcinoma or melanoma cells in immunocompetent syngeneic mice. This inhibitory effect of the Ab appeared to be mediated by dual mechanisms: direct induction of Ab-dependent cellular phagocytosis of tumor cells by macrophages and blockade of CD47-SIRPα signaling that negatively regulates such phagocytosis. The antitumor effect of the Ab was greatly attenuated by selective depletion not only of macrophages but also of NK cells or CD8+ T cells. In addition, the anti-SIRPα Ab also enhances the inhibitory effects of Abs against CD20 and programmed cell death 1 (PD-1) on tumor formation in mice injected with SIRPα-nonexpressing tumor cells. Anti-SIRPα Abs thus warrant further study as a potential new therapy for a broad range of cancers.
Collapse
Affiliation(s)
- Tadahiko Yanagita
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology.,Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Yoji Murata
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology
| | - Daisuke Tanaka
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology
| | - Sei-Ichiro Motegi
- Department of Dermatology, Gunma University Graduate School of Medicine, Gunma, Japan
| | - Eri Arai
- Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan.,Department of Pathology, Keio University School of Medicine, Tokyo, Japan
| | | | - Daisuke Hazama
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology
| | - Ken Washio
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology
| | - Yasuyuki Saito
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology
| | - Takenori Kotani
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology
| | - Hiroshi Ohnishi
- Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Gunma, Japan
| | - Per-Arne Oldenborg
- Department of Integrative Medical Biology, Section for Histology and Cell Biology, Umeå University, Umeå, Sweden
| | - Noel Verjan Garcia
- Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Masayuki Miyasaka
- Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.,MediCity Research Laboratory, University of Turku, Turku, Finland
| | - Osamu Ishikawa
- Department of Dermatology, Gunma University Graduate School of Medicine, Gunma, Japan
| | - Yae Kanai
- Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan.,Department of Pathology, Keio University School of Medicine, Tokyo, Japan
| | - Takahide Komori
- Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Takashi Matozaki
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology
| |
Collapse
|
39
|
Washio K, Fujii S, Kawasaki Y, Nagai S, Hori M, Matsubara K, Hashimoto K, Masaki T. Langerhans cell histiocytosis with molluscum contagiosum: A correlation? J Dermatol 2016; 44:e136-e137. [DOI: 10.1111/1346-8138.13734] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Ken Washio
- Department of Dermatology; Nishi-Kobe Medical Center; Kobe Japan
| | - Shotaro Fujii
- Department of Dermatology; Nishi-Kobe Medical Center; Kobe Japan
| | - Yu Kawasaki
- Department of Pediatrics; Nishi-Kobe Medical Center; Kobe Japan
| | - Sadayuki Nagai
- Department of Pediatrics; Nishi-Kobe Medical Center; Kobe Japan
| | - Masayuki Hori
- Department of Pediatrics; Nishi-Kobe Medical Center; Kobe Japan
| | | | - Kimio Hashimoto
- Department of Pathology; Nishi-Kobe Medical Center; Kobe Japan
| | - Taro Masaki
- Department of Dermatology; Nishi-Kobe Medical Center; Kobe Japan
| |
Collapse
|
40
|
Sasaki N, Yamashita T, Kasahara K, Fukunaga A, Yamaguchi T, Emoto T, Yodoi K, Matsumoto T, Nakajima K, Kita T, Takeda M, Mizoguchi T, Hayashi T, Sasaki Y, Hatakeyama M, Taguchi K, Washio K, Sakaguchi S, Malissen B, Nishigori C, Hirata KI. UVB Exposure Prevents Atherosclerosis by Regulating Immunoinflammatory Responses. Arterioscler Thromb Vasc Biol 2016; 37:66-74. [PMID: 27765767 DOI: 10.1161/atvbaha.116.308063] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2016] [Accepted: 10/10/2016] [Indexed: 01/22/2023]
Abstract
OBJECTIVE UVB irradiation is an established treatment for immunoinflammatory cutaneous disorders and has been shown to suppress cutaneous and systemic inflammatory diseases through modulation of the adaptive immune response. However, it remains unknown whether UVB irradiation prevents an immunoinflammatory disease of arteries such as atherosclerosis. APPROACH AND RESULTS Here, we show that UVB exposure inhibits the development and progression of atherosclerosis in atherosclerosis-prone mice by expanding and enhancing the functional capacity of CD4+ forkhead box P3+ regulatory T cells and regulating proatherogenic T-cell responses. Experimental studies in Langerhans cell-depleted mice revealed that epidermal Langerhans cells play a critical role in UVB-dependent induction of CD4+ forkhead box P3+ regulatory T cells, suppression of proatherogenic T-cell responses, and prevention of atherosclerotic plaque development. CONCLUSIONS Our findings suggest the skin immune system as a novel therapeutic target for atherosclerosis and provide a novel strategy for the treatment and prevention of atherosclerosis.
Collapse
Affiliation(s)
- Naoto Sasaki
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.).
| | - Tomoya Yamashita
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Kazuyuki Kasahara
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Atsushi Fukunaga
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Tomoyuki Yamaguchi
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Takuo Emoto
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Keiko Yodoi
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Takuya Matsumoto
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Kenji Nakajima
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Tomoyuki Kita
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Masafumi Takeda
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Taiji Mizoguchi
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Tomohiro Hayashi
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Yoshihiro Sasaki
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Mayumi Hatakeyama
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Kumiko Taguchi
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Ken Washio
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Shimon Sakaguchi
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Bernard Malissen
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Chikako Nishigori
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| | - Ken-Ichi Hirata
- From the Division of Cardiovascular Medicine, Department of Internal Medicine (N.S., T. Yamashita., K.K., T.E., K.Y., T. Matsumoto, K.N., T.K., M.T., T. Mizoguchi, T.H., Y.S., K.-i.H.) and Division of Dermatology, Department of Internal Related (A.F., M.H., K.T., K.W., C.N.), Kobe University Graduate School of Medicine, Japan; Department of Medical Pharmaceutics, Kobe Pharmaceutical University, Japan (N.S.); Department of Single Molecule Imaging (T. Yamaguchi) and Department of Experimental Immunology (S.S.), World Premier International Immunology Frontier Research Center, Osaka University, Japan; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan (M.T.); and Centre d'Immunologie de Marseille-Luminy and the Centre d'Immunophénomique, UM2 Aix-Marseille Université, Marseille, France (B.M.)
| |
Collapse
|
41
|
Hatakeyama M, Fukunaga A, Washio K, Taguchi K, Nishigori C. Antiinflammatory role of Langerhans cells and apoptotic keratinocytes in UVB-induced cutaneous inflammation. J Dermatol Sci 2016. [DOI: 10.1016/j.jdermsci.2016.08.493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
42
|
Hatakeyama M, Fukunaga A, Washio K, Ogura K, Yamada Y, Horikawa T, Nishigori C. Addition of lafutidine can improve disease activity and lead to better quality of life in refractory cholinergic urticaria unresponsive to histamine H1 antagonists. J Dermatol Sci 2016; 82:137-9. [PMID: 26896422 DOI: 10.1016/j.jdermsci.2016.02.001] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2015] [Revised: 01/21/2016] [Accepted: 02/02/2016] [Indexed: 11/29/2022]
Affiliation(s)
- Mayumi Hatakeyama
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan; Department of Dermatology, Nishi-Kobe Medical Center, 5-7-1 Kojidai, Nishi-ku, Kobe 651-2273, Japan; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan; Department of Dermatology, Nishi-Kobe Medical Center, 5-7-1 Kojidai, Nishi-ku, Kobe 651-2273, Japan; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
| | - Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan; Department of Dermatology, Nishi-Kobe Medical Center, 5-7-1 Kojidai, Nishi-ku, Kobe 651-2273, Japan; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
| | - Kanako Ogura
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan; Department of Dermatology, Nishi-Kobe Medical Center, 5-7-1 Kojidai, Nishi-ku, Kobe 651-2273, Japan; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
| | - Yozo Yamada
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan; Department of Dermatology, Nishi-Kobe Medical Center, 5-7-1 Kojidai, Nishi-ku, Kobe 651-2273, Japan; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
| | - Tatsuya Horikawa
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan; Department of Dermatology, Nishi-Kobe Medical Center, 5-7-1 Kojidai, Nishi-ku, Kobe 651-2273, Japan; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan; Department of Dermatology, Nishi-Kobe Medical Center, 5-7-1 Kojidai, Nishi-ku, Kobe 651-2273, Japan; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
| |
Collapse
|
43
|
Tsuruta A, Washio K, Fukunaga A, Nishigori C. Pirfenidone-induced photoleukomelanoderma in a patient with idiopathic pulmonary fibrosis. J Dermatol 2015; 43:207-9. [DOI: 10.1111/1346-8138.13009] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2015] [Accepted: 05/20/2015] [Indexed: 11/30/2022]
Affiliation(s)
- Aoi Tsuruta
- Division of Dermatology; Department of Internal Related; Kobe University Graduate School of Medicine; Kobe Japan
| | - Ken Washio
- Division of Dermatology; Department of Internal Related; Kobe University Graduate School of Medicine; Kobe Japan
| | - Atsushi Fukunaga
- Division of Dermatology; Department of Internal Related; Kobe University Graduate School of Medicine; Kobe Japan
| | - Chikako Nishigori
- Division of Dermatology; Department of Internal Related; Kobe University Graduate School of Medicine; Kobe Japan
| |
Collapse
|
44
|
Oda Y, Fukunaga A, Tsujimoto M, Hatakeyama M, Washio K, Nishigori C. Combined cholinergic urticaria and cold-induced cholinergic urticaria with acquired idiopathic generalized anhidrosis. Allergol Int 2015; 64:214-5. [PMID: 25838106 DOI: 10.1016/j.alit.2014.12.004] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2014] [Revised: 12/08/2014] [Accepted: 12/14/2014] [Indexed: 11/17/2022] Open
Affiliation(s)
- Yoshiko Oda
- Division of Dermatology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan.
| | - Mariko Tsujimoto
- Division of Dermatology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan
| | - Mayumi Hatakeyama
- Division of Dermatology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan
| | - Ken Washio
- Division of Dermatology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan
| |
Collapse
|
45
|
Washio K, Kotani T, Saito Y, Respatika D, Murata Y, Kaneko Y, Okazawa H, Ohnishi H, Fukunaga A, Nishigori C, Matozaki T. Dendritic cell SIRPα regulates homeostasis of dendritic cells in lymphoid organs. Genes Cells 2015; 20:451-63. [PMID: 25818708 DOI: 10.1111/gtc.12238] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2015] [Accepted: 02/18/2015] [Indexed: 12/13/2022]
Abstract
Signal regulatory protein α (SIRPα), an immunoglobulin superfamily protein that is expressed predominantly in myeloid lineage cells such as dendritic cells (DCs) or macrophages, mediates cell-cell signaling. In the immune system, SIRPα is thought to be important for homeostasis of DCs, but it remains unclear whether SIRPα intrinsic to DCs is indeed indispensable for such functional role. Thus, we here generated the mice, in which SIRPα was specifically ablated in CD11c(+) DCs (Sirpa(Δ) (DC) ). Sirpa(Δ) (DC) mice manifested a marked reduction of CD4(+) CD8α(-) conventional DCs (cDCs) in the secondary lymphoid organs, as well as of Langerhans cells in the epidermis. Such reduction of cDCs in Sirpa(Δ) (DC) mice was comparable to that apparent with the mice, in which SIRPα was systemically ablated. Expression of SIRPα in DCs was well correlated with that of either endothelial cell-selective adhesion molecule (ESAM) or Epstein-Barr virus-induced molecule 2 (EBI2), both of which were also implicated in the regulation of DC homeostasis. Indeed, ESAM(+) or EBI2(+) cDCs were markedly reduced in the spleen of Sirpa(Δ) (DC) mice. Thus, our results suggest that SIRPα intrinsic to CD11c(+) DCs is essential for homeostasis of cDCs in the secondary lymphoid organs and skin.
Collapse
Affiliation(s)
- Ken Washio
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe, 650-0017, Japan.,Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe, 650-0017, Japan
| | - Takenori Kotani
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe, 650-0017, Japan
| | - Yasuyuki Saito
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe, 650-0017, Japan
| | - Datu Respatika
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe, 650-0017, Japan
| | - Yoji Murata
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe, 650-0017, Japan
| | - Yoriaki Kaneko
- Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan
| | - Hideki Okazawa
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe, 650-0017, Japan
| | - Hiroshi Ohnishi
- Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8514, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe, 650-0017, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe, 650-0017, Japan
| | - Takashi Matozaki
- Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe, 650-0017, Japan
| |
Collapse
|
46
|
Fukunaga A, Hatakeyama M, Tsujimoto M, Oda Y, Washio K, Nishigori C. Steroid treatment can improve the impaired quality of life of patients with acquired idiopathic generalized anhidrosis. Br J Dermatol 2014; 172:537-8. [PMID: 25060903 DOI: 10.1111/bjd.13285] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- A Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, , 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
| | | | | | | | | | | |
Collapse
|
47
|
Kaibuchi N, Iwata T, Washio K, Kato Y, Okamoto T, Yamato M, Okano T, Ando T. Cytotherapeutic use of allogeneic mesenchymal stem cell sheets for bisphosphonate-related osteonecrosis of the jaw in a rat model. J Oral Maxillofac Surg 2014. [DOI: 10.1016/j.joms.2014.06.149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
48
|
Washio K, Fukunaga A, Terai M, Hitomi K, Yamanishi K, Nishigori C. Hypohidrosis plays a crucial role in the vicious circle of bathing suit ichthyosis: a case with summer exacerbation. Acta Derm Venereol 2014; 94:349-50. [PMID: 24158451 DOI: 10.2340/00015555-1739] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- Ken Washio
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
| | | | | | | | | | | |
Collapse
|
49
|
Fukunaga A, Washio K, Ogura K, Taguchi K, Chiyomaru K, Ohno Y, Masaki T, Nagai H, Nagano T, Oka M, Nishigori C. Onychomycosis as a warning sign for peripheral arterial disease. Acta Derm Venereol 2013; 93:747-8. [PMID: 23529206 DOI: 10.2340/00015555-1576] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Washio K, Nakamura A, Fukuda S, Hashimoto T, Horikawa T. A case of lichen planus pemphigoides successfully treated with a combination of cyclosporine a and prednisolone. Case Rep Dermatol 2013; 5:84-7. [PMID: 23626545 PMCID: PMC3617966 DOI: 10.1159/000350285] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
Abstract
Lichen planus pemphigoides (LPP) is a rare clinical variant of bullous pemphigoid (BP). A 35-year-old female patient presented to our hospital complaining of pruritic violaceous-colored plaques or papules on the extremities. Tense vesicles were also seen on the soles. Skin biopsies from the papules and vesicles demonstrated lichen planus and BP, respectively. Direct immunofluorescence demonstrated linear IgG and C3 deposition on the basement membrane zone. Indirect immunofluorescence on 1 M NaCl split skin detected IgG reactivity with the epidermal side. Enzyme-linked immunosorbent assay also detected anti-BP180 antibodies. After treatment with oral prednisolone alone had failed, low-dose cyclosporine A (CyA) was added. The clinical symptoms immediately improved and the titer of the anti-BP180 antibodies decreased. Although there is little information about the treatment of recalcitrant LPP, additional CyA appeared to be beneficial.
Collapse
Affiliation(s)
- Ken Washio
- Department of Dermatology, Nishi-Kobe Medical Center, Kobe, Kurume University School of Medicine and Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan
| | | | | | | | | |
Collapse
|